SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000913849-16-000395
Filing Date
2016-02-10
Accepted
2016-02-11 08:24:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 CERULEAN PHARMA INC. SCHEDULE 13G/A sc13ga_020916.htm SC 13G/A 44005
  Complete submission text file 0000913849-16-000395.txt   45564
Mailing Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601
Business Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601 312-899-5034
CVF, LLC (Filed by) CIK: 0001112278 (see all company filings)

IRS No.: 367227242
Type: SC 13G/A

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88094 | Film No.: 161408088
SIC: 2834 Pharmaceutical Preparations